[4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone

C25H22F6N4O3S — CID 42625949

IUPAC[4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone
SMILESO=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3cn[nH]c3)cc(C(F)(F)F)c2)CC1
InChIInChI=1S/C25H22F6N4O3S/c26-24(27,28)18-3-1-15(2-4-18)21-12-22(21)23(36)34-5-7-35(8-6-34)39(37,38)20-10-16(17-13-32-33-14-17)9-19(11-20)25(29,30)31/h1-4,9-11,13-14,21-22H,5-8,12H2,(H,32,33)/t21-,22+/m0/s1
InChIKeyGFYAPNPWRHIAKF-FCHUYYIVSA-N
MW572.53 g/mol
LogP4.75
Rot. Bonds5

About [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone

[4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone (PubChem CID 42625949) has the molecular formula C25H22F6N4O3S and a molecular weight of 572.53 g/mol. Its IUPAC name is [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone.

Molecular Properties

Compound Name[4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone
PubChem CID42625949
Molecular FormulaC25H22F6N4O3S
Molecular Weight572.53 g/mol
Exact Mass572.13
IUPAC Name[4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone
SMILESO=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3cn[nH]c3)cc(C(F)(F)F)c2)CC1
InChIInChI=1S/C25H22F6N4O3S/c26-24(27,28)18-3-1-15(2-4-18)21-12-22(21)23(36)34-5-7-35(8-6-34)39(37,38)20-10-16(17-13-32-33-14-17)9-19(11-20)25(29,30)31/h1-4,9-11,13-14,21-22H,5-8,12H2,(H,32,33)/t21-,22+/m0/s1
InChIKeyGFYAPNPWRHIAKF-FCHUYYIVSA-N
XLogP4.75
TPSA86.37 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms39
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500572.53
LogP ≤ 54.75
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(4-(3-(1H-pyrazol-5-yl)-5-(trifluoromethyl)phenylsulfonyl)piperazin-1-yl)((1R,2R)-2-(4-(trifluoromethyl)phenyl)cyclopropyl)methanone
CID 42625636
(4-(3-(3-methyl-1H-pyrazol-4-yl)-5-(trifluoromethyl)phenylsulfonyl)piperazin-1-yl)((1R,2R)-2-(4-(trifluoromethyl)phenyl)cyclopropyl)methanone
CID 42626020
(4-(3-(2H-1,2,3-triazol-4-yl)-5-(trifluoromethyl)phenylsulfonyl)piperazin-1-yl)((1R,2R)-2-(4-(trifluoromethyl)phenyl)cyclopropyl)methanone
CID 42626023
(5-phenyl-1H-pyrazol-4-yl)-[4-[3-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]methanone
CID 32148572
[4-[3-(2H-triazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone
CID 57896618
1-{[3-(3-methyl-1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonyl}-4-({2-[4-(trifluoromethyl)phenyl]cyclopropyl}carbonyl)piperazine
CID 57896619
4-[[4-[4-[4-(3,3-difluoro-4-phenylpyrrolidin-1-yl)-4-oxobutyl]-1H-pyrazol-5-yl]piperidin-1-yl]methyl]benzenesulfonamide
CID 123314533
N-[2-[[3-(5-methyl-1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylamino]ethyl]-2-[4-(trifluoromethyl)phenyl]cyclopropane-1-carboxamide
CID 162600063
(4,4-difluorocyclohexyl)-[4-[2,3-difluoro-4-(1H-pyrazol-4-yl)phenyl]piperidin-1-yl]methanone
CID 169094691
(2,2-difluorocyclohexyl)-[4-[2,3-difluoro-4-(1H-pyrazol-4-yl)phenyl]piperidin-1-yl]methanone
CID 176618531
[5-(4-fluorophenyl)-1H-pyrazol-4-yl]-[4-[3-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]methanone
CID 17516299
1-(benzenesulfonyl)-6-phenyl-N-[2-(1H-pyrazol-4-yl)ethyl]piperidine-3-carboxamide
CID 67253779

Frequently Asked Questions

What is the IUPAC name of [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone?
The IUPAC name of [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone (CID 42625949) is [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone.
What is the SMILES notation for [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone?
The canonical SMILES for [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone is O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3cn[nH]c3)cc(C(F)(F)F)c2)CC1.
What is the InChIKey of [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone?
The InChIKey is GFYAPNPWRHIAKF-FCHUYYIVSA-N. The full InChI is InChI=1S/C25H22F6N4O3S/c26-24(27,28)18-3-1-15(2-4-18)21-12-22(21)23(36)34-5-7-35(8-6-34)39(37,38)20-10-16(17-13-32-33-14-17)9-19(11-20)25(29,30)31/h1-4,9-11,13-14,21-22H,5-8,12H2,(H,32,33)/t21-,22+/m0/s1.
What are the key properties of [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone?
[4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone has a molecular weight of 572.53 g/mol, XLogP of 4.75, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[3-(1H-pyrazol-4-yl)-5-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-[(1R,2R)-2-[4-(trifluoromethyl)phenyl]cyclopropyl]methanone is sourced from PubChem (CID 42625949), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).